•
Jun 30, 2015

EyePoint Pharmaceuticals Q4 2015 Earnings Report

Total Revenue
$409K
Previous year: $292K
+40.1%
EPS
-$1.7
Previous year: -$1.4
+21.4%
Gross Profit
-$2.79M
Previous year: $214K
-1403.3%
Cash and Equivalents
$19.1M
Previous year: $15.3M
+24.7%
Total Assets
$32.4M
Previous year: $22.7M
+42.8%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals